Protagonist Therapeutics, Inc PTGX
PTGX among the 162 companies we cover
Where it stands · the better end on the right. The band holds the middle half; the line is the median.
PTGX and 9 peers, year by year
The 9 Health care companies closest to PTGX in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, Inc | FY2025 | $46.0M | −89.4% | - | −343.6% | −282.8% | 121.9% | −21.2% | - |
| VCYT Veracyte, Inc. | FY2025 | $517.1M | +16.0% | 70.1% | 11.2% | 12.8% | 24.5% | 5.1% | - |
| ADMA Adma Biologics, Inc. | FY2025 | $510.2M | +19.6% | 57.4% | 37.5% | 28.8% | 5.5% | 30.8% | 0.15 |
| KRYS Krystal Biotech, Inc. | FY2025 | $389.1M | +33.9% | - | 41.5% | 52.6% | 48.5% | 16.8% | - |
| WGS GeneDx Holdings Corp. | FY2025 | $427.5M | +40.0% | 69.7% | −3.1% | −4.9% | 3.3% | −6.8% | 0.18 |
| UFPT UFP Technologies Inc | FY2025 | $602.8M | +19.5% | 28.3% | 15.3% | 11.3% | - | 16.1% | 0.32 |
| ZLAB Zai Lab Ltd | FY2025 | $460.2M | +15.0% | - | −49.9% | −38.1% | −34.5% | −24.5% | 0.29 |
| MIRM Mirum Pharmaceuticals, Inc. | FY2025 | $521.3M | +54.7% | - | −4.2% | −4.5% | 10.5% | −7.4% | - |
| TWST Twist Bioscience Corp | FY2025 | $376.6M | +20.3% | - | −36.2% | −20.6% | −20.1% | −16.4% | - |
| TARS Tarsus Pharmaceuticals, Inc. | FY2025 | $451.4M | +147% | - | −15.7% | −14.7% | −4.9% | −19.3% | 0.21 |
Each company, year by year
Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL
Who rewrote the most
Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before
Revenue, FY2016 to FY2025
Revenue as reported in the 10-K.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PTGX Dec | - | $20.1M | $30.9M | $231K | $28.6M | $27.4M | $26.6M | $60.0M | $434.4M | $46.0M |
| VCYT Dec | $65.1M | $72.0M | $92.0M | $120.4M | $117.5M | $219.5M | $296.5M | $361.1M | $445.8M | $517.1M |
| ADMA Dec | $10.7M | $22.8M | $17.0M | $29.3M | $42.2M | $80.9M | $154.1M | $258.2M | $426.5M | $510.2M |
| KRYS Dec | - | - | - | - | - | $0 | $0 | $50.7M | $290.5M | $389.1M |
| WGS Dec | - | - | - | $196.2M | $179.3M | $212.2M | $234.7M | $202.6M | $305.4M | $427.5M |
| UFPT Dec | $146.1M | $147.8M | $190.5M | $198.4M | $179.4M | $206.3M | $353.8M | $400.1M | $504.4M | $602.8M |
| ZLAB Dec | - | - | $129K | $13.0M | $49.0M | $144.3M | $215.0M | $266.7M | $399.0M | $460.2M |
| MIRM Dec | - | - | - | - | $0 | $19.1M | $77.1M | $186.4M | $336.9M | $521.3M |
| TWST Sep | - | $10.8M | $25.4M | $54.4M | $90.1M | $132.3M | $203.6M | $245.1M | $313.0M | $376.6M |
| TARS Dec | - | - | - | - | $0 | $57.0M | $25.8M | $17.4M | $183.0M | $451.4M |
| Peer median | $65.1M | $47.4M | $25.4M | $87.4M | $69.5M | $132.3M | $203.6M | $245.1M | $336.9M | $460.2M |
Sales growth, FY2016 to FY2025
Revenue against the fiscal year before.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PTGX Dec | - | - | +54.1% | −99.3% | n/m | −4.4% | −2.8% | +126% | +624% | −89.4% |
| VCYT Dec | +31.5% | +10.6% | +27.9% | +30.8% | −2.4% | +86.8% | +35.1% | +21.8% | +23.5% | +16.0% |
| ADMA Dec | +48.5% | +113% | −25.4% | +72.8% | +43.9% | +91.7% | +90.4% | +67.6% | +65.2% | +19.6% |
| KRYS Dec | - | - | - | - | - | - | - | - | +473% | +33.9% |
| WGS Dec | - | - | - | - | −8.6% | +18.3% | +10.6% | −13.7% | +50.8% | +40.0% |
| UFPT Dec | +5.2% | +1.2% | +28.8% | +4.2% | −9.6% | +15.0% | +71.5% | +13.1% | +26.1% | +19.5% |
| ZLAB Dec | - | - | - | n/m | +277% | +194% | +47.6% | +25.4% | +49.1% | +15.0% |
| MIRM Dec | - | - | - | - | - | - | +303% | +142% | +80.8% | +54.7% |
| TWST Sep | - | - | +136% | +114% | +65.7% | +46.9% | +53.8% | +20.4% | +27.7% | +20.3% |
| TARS Dec | - | - | - | - | - | - | −54.7% | −32.4% | +949% | +147% |
| Peer median | +31.5% | +10.6% | +28.3% | +51.8% | +20.7% | +66.9% | +50.7% | +21.1% | +50.8% | +20.3% |
Gross margin, FY2016 to FY2025
Gross profit / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PTGX Dec | - | - | - | - | - | - | - | - | - | - |
| VCYT Dec | - | - | - | - | - | - | 59.2% | 63.6% | 66.9% | 70.1% |
| ADMA Dec | 40.3% | −28.1% | −148.4% | - | −45.2% | 1.4% | 22.9% | 34.4% | 51.5% | 57.4% |
| KRYS Dec | - | - | - | - | - | - | - | - | - | - |
| WGS Dec | - | - | - | 42.2% | 2.2% | −7.8% | −11.4% | 44.4% | 63.6% | 69.7% |
| UFPT Dec | 23.7% | 24.0% | 25.4% | 27.2% | 24.9% | 24.8% | 25.5% | 28.1% | 29.1% | 28.3% |
| ZLAB Dec | - | - | 66.6% | - | - | - | - | - | - | - |
| MIRM Dec | - | - | - | - | - | - | - | - | - | - |
| TWST Sep | - | - | - | - | - | - | - | - | - | - |
| TARS Dec | - | - | - | - | - | - | - | - | - | - |
| Peer median | - | - | 25.4% | - | 2.2% | 1.4% | 24.2% | 39.4% | 57.6% | 63.6% |
Operating margin, FY2016 to FY2025
Operating income / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PTGX Dec | - | −188.9% | −136.7% | n/m | −225.4% | −460.0% | −494.2% | −156.1% | 58.2% | −343.6% |
| VCYT Dec | −44.3% | −36.9% | −24.2% | −12.6% | −30.1% | −37.3% | −13.9% | −23.8% | 3.6% | 11.2% |
| ADMA Dec | −162.6% | −172.7% | −354.9% | −141.1% | −153.8% | −72.1% | −25.5% | 8.4% | 32.6% | 37.5% |
| KRYS Dec | - | - | - | - | - | - | - | −216.2% | 22.6% | 41.5% |
| WGS Dec | - | - | - | −15.5% | −134.9% | −210.3% | −284.5% | −89.2% | −7.6% | −3.1% |
| UFPT Dec | 8.4% | 7.9% | 10.3% | 12.5% | 9.3% | 10.3% | 15.7% | 14.4% | 16.0% | 15.3% |
| ZLAB Dec | - | - | n/m | n/m | −616.4% | −485.1% | −188.0% | −137.4% | −70.7% | −49.9% |
| MIRM Dec | - | - | - | - | - | −906.1% | −170.3% | −58.6% | −26.0% | −4.2% |
| TWST Sep | - | −543.2% | −277.5% | −200.1% | −155.5% | −115.4% | −115.3% | −88.6% | −70.6% | −36.2% |
| TARS Dec | - | - | - | - | - | −21.3% | −242.9% | −820.5% | −65.9% | −15.7% |
| Peer median | −44.3% | −104.8% | −150.8% | −15.5% | −144.4% | −93.8% | −142.8% | −88.6% | −7.6% | −3.1% |
Net margin, FY2016 to FY2025
Net income / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PTGX Dec | - | −184.2% | −125.9% | n/m | −231.1% | −458.9% | −479.3% | −131.6% | 63.3% | −282.8% |
| VCYT Dec | −48.2% | −43.1% | −25.0% | −10.5% | −29.7% | −34.4% | −12.3% | −20.6% | 5.4% | 12.8% |
| ADMA Dec | −183.1% | −192.3% | −387.1% | −164.5% | −179.4% | −88.5% | −42.8% | −10.9% | 46.4% | 28.8% |
| KRYS Dec | - | - | - | - | - | - | - | 21.6% | 30.7% | 52.6% |
| WGS Dec | - | - | - | −15.1% | −134.6% | −115.6% | −233.9% | −86.8% | −17.1% | −4.9% |
| UFPT Dec | 5.5% | 6.2% | 7.5% | 10.0% | 7.5% | 7.7% | 11.8% | 11.2% | 11.7% | 11.3% |
| ZLAB Dec | - | - | n/m | n/m | −549.3% | −488.2% | −206.1% | −125.5% | −64.4% | −38.1% |
| MIRM Dec | - | - | - | - | - | −438.9% | −176.0% | −87.7% | −26.1% | −4.5% |
| TWST Sep | - | −550.8% | −280.2% | −198.0% | −155.3% | −114.9% | −107.0% | −83.5% | −66.7% | −20.6% |
| TARS Dec | - | - | - | - | - | −24.2% | −240.5% | −778.9% | −63.2% | −14.7% |
| Peer median | −48.2% | −117.7% | −152.6% | −15.1% | −144.9% | −101.7% | −141.5% | −83.5% | −17.1% | −4.5% |
Free cash flow, FY2016 to FY2025
Cash from operations minus capital spending.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PTGX Dec | −$30.3M | $3.2M | −$50.4M | −$42.5M | −$73.0M | −$109.0M | −$108.9M | −$70.8M | $182.8M | $56.1M |
| VCYT Dec | −$32.2M | −$25.7M | −$15.4M | −$6.0M | −$12.5M | −$37.0M | −$1.0M | $34.3M | $63.8M | $126.6M |
| ADMA Dec | −$18.3M | −$39.9M | −$64.8M | −$80.0M | −$114.7M | −$125.9M | −$73.4M | $4.0M | $110.4M | $27.8M |
| KRYS Dec | −$1.3M | −$4.1M | −$11.7M | −$25.1M | −$40.9M | −$116.3M | −$153.5M | −$100.6M | $119.2M | $188.9M |
| WGS Dec | - | - | - | −$30.7M | −$117.2M | −$199.8M | −$326.3M | −$185.4M | −$34.0M | $14.3M |
| UFPT Dec | $2.1M | $7.1M | $15.9M | $25.5M | $20.7M | $8.9M | $4.0M | $30.8M | $56.9M | - |
| ZLAB Dec | −$34.4M | −$41.5M | −$107.6M | −$197.0M | −$226.2M | −$567.5M | −$392.2M | −$205.4M | −$220.5M | −$158.9M |
| MIRM Dec | - | - | - | −$39.6M | −$89.3M | −$132.8M | −$120.4M | −$71.1M | $9.3M | $54.9M |
| TWST Sep | - | −$57.9M | −$69.9M | −$102.7M | −$152.1M | −$139.3M | −$226.2M | −$170.3M | −$69.2M | −$75.6M |
| TARS Dec | - | - | - | −$3.8M | −$21.6M | $3.2M | −$49.5M | −$119.0M | −$84.6M | −$22.3M |
| Peer median | −$18.3M | −$32.8M | −$40.1M | −$30.7M | −$89.3M | −$125.9M | −$120.4M | −$100.6M | $9.3M | $21.0M |
FCF margin, FY2016 to FY2025
Free cash flow / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PTGX Dec | - | 16.0% | −163.1% | n/m | −254.8% | −398.3% | −409.8% | −118.1% | 42.1% | 121.9% |
| VCYT Dec | −49.5% | −35.7% | −16.7% | −5.0% | −10.7% | −16.9% | −0.3% | 9.5% | 14.3% | 24.5% |
| ADMA Dec | −172.1% | −175.5% | −381.4% | −272.6% | −271.7% | −155.5% | −47.6% | 1.6% | 25.9% | 5.5% |
| KRYS Dec | - | - | - | - | - | - | - | −198.4% | 41.0% | 48.5% |
| WGS Dec | - | - | - | −15.6% | −65.4% | −94.2% | −139.0% | −91.5% | −11.1% | 3.3% |
| UFPT Dec | 1.4% | 4.8% | 8.3% | 12.8% | 11.5% | 4.3% | 1.1% | 7.7% | 11.3% | - |
| ZLAB Dec | - | - | n/m | n/m | −462.0% | −393.3% | −182.4% | −77.0% | −55.3% | −34.5% |
| MIRM Dec | - | - | - | - | - | −693.8% | −156.3% | −38.1% | 2.8% | 10.5% |
| TWST Sep | - | −537.7% | −274.7% | −188.8% | −168.8% | −105.3% | −111.1% | −69.5% | −22.1% | −20.1% |
| TARS Dec | - | - | - | - | - | 5.5% | −191.9% | −682.0% | −46.2% | −4.9% |
| Peer median | −49.5% | −105.6% | −145.7% | −15.6% | −117.1% | −99.7% | −125.1% | −69.5% | 2.8% | 4.4% |
Return on equity, FY2016 to FY2025
Net income / shareholders' equity at the year end.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PTGX Dec | −42.5% | −30.6% | −34.6% | −96.5% | −23.7% | −41.8% | −59.1% | −23.5% | 40.8% | −21.2% |
| VCYT Dec | −52.6% | −83.3% | −28.8% | −5.3% | −8.3% | −6.9% | −3.4% | −7.1% | 2.1% | 5.1% |
| ADMA Dec | n/m | −108.5% | n/m | −184.3% | −85.8% | −50.8% | −43.4% | −20.9% | 56.6% | 30.8% |
| KRYS Dec | n/m | −16.0% | −9.6% | −9.4% | −11.0% | −11.7% | −26.8% | 1.4% | 9.4% | 16.8% |
| WGS Dec | - | - | - | n/m | n/m | −63.2% | n/m | −77.1% | −21.3% | −6.8% |
| UFPT Dec | 7.0% | 7.4% | 10.2% | 12.2% | 7.6% | 8.2% | 17.6% | 15.7% | 17.2% | 16.1% |
| ZLAB Dec | n/m | −21.4% | −55.4% | −66.2% | −23.0% | −51.1% | −42.4% | −42.0% | −30.6% | −24.5% |
| MIRM Dec | - | - | - | −40.3% | −60.0% | −69.9% | −95.5% | −65.7% | −39.0% | −7.4% |
| TWST Sep | - | n/m | n/m | −70.8% | −41.6% | −26.2% | −27.6% | −32.8% | −44.2% | −16.4% |
| TARS Dec | - | - | n/m | n/m | −16.2% | −8.3% | −32.2% | −69.0% | −51.5% | −19.3% |
| Peer median | - | −21.4% | −19.2% | −40.3% | −19.6% | −26.2% | −29.9% | −32.8% | −21.3% | −6.8% |
Debt / equity, FY2016 to FY2025
Total debt / shareholders' equity at the year end.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PTGX Dec | - | - | - | 0.12 | - | - | - | - | - | - |
| VCYT Dec | 0.42 | 0.67 | 0.32 | 0.00 | 0.00 | 0.00 | - | - | - | - |
| ADMA Dec | n/m | 0.07 | 0.14 | 0.00 | 1.05 | - | - | - | 0.21 | 0.15 |
| KRYS Dec | - | - | - | - | - | - | - | - | - | - |
| WGS Dec | - | - | - | - | n/m | 0.03 | 0.04 | 0.25 | 0.23 | 0.18 |
| UFPT Dec | 0.01 | - | 0.18 | - | 0.00 | 0.39 | 0.23 | 0.11 | 0.55 | 0.32 |
| ZLAB Dec | - | - | 0.01 | 0.02 | - | - | - | 0.00 | 0.16 | 0.29 |
| MIRM Dec | - | - | - | - | - | - | - | - | - | - |
| TWST Sep | - | - | n/m | 0.05 | 0.01 | - | - | - | - | - |
| TARS Dec | - | - | - | - | - | 0.00 | 0.10 | 0.15 | 0.32 | 0.21 |
| Peer median | - | - | 0.16 | 0.01 | 0.01 | 0.01 | 0.10 | 0.13 | 0.23 | 0.21 |
EPS (diluted), FY2016 to FY2025
Diluted earnings per share, on today's share count after splits.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PTGX Dec | −$5.80 | −$2.09 | −$1.74 | −$2.98 | −$1.92 | −$2.71 | −$2.60 | −$1.39 | $4.23 | −$2.05 |
| VCYT Dec | −$1.09 | −$0.91 | −$0.62 | −$0.27 | −$0.66 | −$1.11 | −$0.51 | −$1.02 | $0.31 | $0.82 |
| ADMA Dec | −$1.61 | −$1.91 | −$1.45 | −$0.89 | −$0.88 | −$0.51 | −$0.33 | −$0.13 | $0.81 | $0.60 |
| KRYS Dec | −$1.31 | −$1.48 | −$0.97 | −$1.20 | −$1.71 | −$3.13 | −$5.49 | $0.39 | $3.00 | $6.84 |
| WGS Dec | - | - | - | −$264056.00 | −$47036.00 | −$2.27 | −$53.63 | −$7.23 | −$1.94 | −$0.73 |
| UFPT Dec | $1.10 | $1.26 | $1.93 | $2.63 | $1.77 | $2.09 | $5.45 | $5.83 | $7.58 | $8.75 |
| ZLAB Dec | −$3.97 | −$2.32 | −$2.64 | −$3.03 | −$0.35 | −$0.76 | −$0.46 | −$0.35 | −$0.26 | −$0.16 |
| MIRM Dec | - | - | - | −$4.58 | −$4.09 | −$2.77 | −$4.02 | −$4.00 | −$1.85 | −$0.47 |
| TWST Sep | - | −$24.49 | −$25.51 | −$3.92 | −$3.57 | −$3.15 | −$4.04 | −$3.60 | −$3.60 | −$1.30 |
| TARS Dec | - | - | - | −$1.98 | −$4.32 | −$0.67 | −$2.52 | −$4.62 | −$3.07 | −$1.59 |
| Peer median | −$1.31 | −$1.69 | −$1.21 | −$1.98 | −$1.71 | −$1.11 | −$2.52 | −$1.02 | −$0.26 | −$0.16 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out PTGX and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more
Sources
Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.
Also
Financials: PTGX's own statements, year by year. Compare: the whole peer group on one page.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PTGX/export.csv") into a cell.